Details of the Drug-Related molecule(s) Expression Atlas

General Information of Drug (ID: DMFMBZ9)

Drug Name

BAS-09534324 Drug Info

Synonyms

BAS 09534324; BAS-09534324; CHEMBL376993; AC1LM0SZ; MolPort-002-015-109; ZINC815475; BDBM50187571; STK175770; AKOS000654857; MCULE-5021008908; 2-methoxy-4-methylsulfanyl-N-(5-phenethyl-1,3,4-thiadiazol-2-yl)benzamide; 2-methoxy-4-(methylthio)-N-(5-phenethyl-1,3,4-thiadiazol-2-yl)benzamide; 2-methoxy-4-(methylsulfanyl)-N~1~-(5-phenethyl-1,3,4-thiadiazol-2-yl)benzamide; 2-Methoxy-4-methylsulfanyl-N-(5-phenethyl-[1,3,4]thiadiazol-2-yl)-benzamide; 2-methoxy-4-(methylthio)-N-[5-(2-phenylethyl)-1,3,4-thiadiazol-2-yl]benzamide

Indication

Disease Entry	ICD 11	Status	REF
Discovery agent	N.A.	Investigative	[1]

Cross-matching ID

PubChem CID: 1094114
TTD Drug ID: DMFMBZ9

Molecule(s) Related to This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Proto-oncogene c-Src (SRC)	TT6PKBN	SRC_HUMAN	Inhibitor	[1]
Tyrosine-protein kinase ABL1 (ABL)	TT3PJMV	ABL1_HUMAN	Inhibitor	[1]

------------------------------------------------------------------------------------

The Expression Level of Molecule(s) in Normal Tissue of Major ADME-Related Organs

Molecule	Molecule Type	Gene Name	Liver	Colon	Kidney	Small Intestine
Proto-oncogene c-Src (SRC)	DTT	SRC	2.907	3.35	3.498	4.75

Molecule Expression Atlas in Normal Tissue of Major ADME-related organs

The Expression Level of Molecule(s) between Disease Section and Healthy Individual Tissue

The Studied Disease

Discovery agent

ICD Disease Classification

N.A.

Molecule Name	Molecule Type	Gene Name	p-value	Fold-Change	Z-score
Proto-oncogene c-Src (SRC)	DTT	SRC	7.46E-03	-0.2	-1.24
Tyrosine-protein kinase ABL1 (ABL)	DTT	ABL1	6.28E-04	0.33	2.07

Molecular Expression Atlas between Disease Section and Healthy Individual Tissue

References

1	A combination of docking/dynamics simulations and pharmacophoric modeling to discover new dual c-Src/Abl kinase inhibitors. J Med Chem. 2006 Jun 1;49(11):3278-86.